Zoetis Inc (ZTS)
175.12
+0.48
(+0.28%)
USD |
NYSE |
Nov 15, 16:00
175.12
0.00 (0.00%)
After-Hours: 20:00
Zoetis Gross Profit (Annual): 5.983B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.983B |
| December 31, 2022 | 5.626B |
| December 31, 2021 | 5.473B |
| December 31, 2020 | 4.618B |
| December 31, 2019 | 4.268B |
| December 31, 2018 | 3.914B |
| December 31, 2017 | 3.532B |
| December 31, 2016 | 3.222B |
| Date | Value |
|---|---|
| December 31, 2015 | 3.027B |
| December 31, 2014 | 3.068B |
| December 31, 2013 | 2.892B |
| December 31, 2012 | 2.773B |
| December 31, 2011 | 2.581B |
| December 31, 2010 | 2.138B |
| December 31, 2009 | 1.682B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
4.268B
Minimum
2019
5.983B
Maximum
2023
5.194B
Average
5.473B
Median
2021
Gross Profit (Annual) Benchmarks
| Pfizer Inc | 33.54B |
| Regeneron Pharmaceuticals Inc | 11.30B |
| Vertex Pharmaceuticals Inc | 8.607B |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Biomarin Pharmaceutical Inc | 1.904B |